Podrobno

Activities on the interface of journalism and meteorology
ID Benestad, Rasmus E. (Avtor), ID Cegnar, Tanja (Urednik)

URLURL - Predstavitvena datoteka, za dostop obiščite http://meetings.copernicus.org/ems2011/ Povezava se odpre v novem oknu

Jezik:Angleški jezik
Ključne besede:vreme, podnebje, klimatske spremembe, vremenske ujme, obveščanje, internet, vremenska napoved, radio, televizija, komunikacijska tehnologija, zborniki, DVD
Vrsta gradiva:Zbornik
Organizacija:BF - Biotehniška fakulteta
Kraj izida:Berlin
Založnik:European Meteorological Society
Leto izida:2012
Št. strani:1 optični disk (DVD-ROM)
PID:20.500.12556/RUL-36418 Povezava se odpre v novem oknu
UDK:551.5:659.3(082)(086.82)
COBISS.SI-ID:261764096 Povezava se odpre v novem oknu
Datum objave v RUL:10.07.2015
Število ogledov:1540
Število prenosov:279
Metapodatki:XML DC-XML DC-RDF
:
BENESTAD, Rasmus E., 2012, Activities on the interface of journalism and meteorology [na spletu]. 2012. Berlin : European Meteorological Society. [Dostopano 29 marec 2025]. Pridobljeno s: http://meetings.copernicus.org/ems2011/
Kopiraj citat
Objavi na:Bookmark and Share

Podobna dela

Podobna dela v RUL:
  1. ǂThe ǂimportance of cancer stem cells and epithelial-mesenchymal transition in the progression of non-small cell lung cancer
  2. Gene expression levels of the prolyl hydroxylase domain proteins PHD1 and PHD2 but not PHD3 are decreased in primary tumours and correlate with poor prognosis of patients with surgically resected non-small-cell lung cancer
  3. Study of phosphatidylethanolamine N-methyltransferase gene expression in non-small cell lung cancer tissue
  4. Usefulness of immunohistochemically determined epidermal growth factor receptor mutations in lung cancer
  5. Diabetes mellitus and physical activity
Podobna dela v drugih slovenskih zbirkah:
  1. Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small cell lung cancer
  2. Outsourcing predictive biomarker testing in non-small cell carcinoma
  3. Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  4. Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  5. NSCLC molecular testing in Central and Eastern European countries

Nazaj